HC Surgical Specialists Limited
HC Surgical Specialists Limited Fundamental Analysis
HC Surgical Specialists Limited (1B1.SI) shows strong financial fundamentals with a PE ratio of 8.43, profit margin of 47.09%, and ROE of 34.20%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 77.9/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 1B1.SI's fundamental strength across five key dimensions:
Efficiency Score
Excellent1B1.SI demonstrates superior asset utilization.
Valuation Score
Excellent1B1.SI trades at attractive valuation levels.
Growth Score
Moderate1B1.SI shows steady but slowing expansion.
Financial Health Score
Excellent1B1.SI maintains a strong and stable balance sheet.
Profitability Score
Excellent1B1.SI achieves industry-leading margins.
Key Financial Metrics
Is 1B1.SI Expensive or Cheap?
P/E Ratio
1B1.SI trades at 8.43 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 1B1.SI's PEG of 0.22 indicates potential undervaluation.
Price to Book
The market values HC Surgical Specialists Limited at 2.71 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 14.04 times EBITDA. This signals the market has high growth expectations.
How Well Does 1B1.SI Make Money?
Net Profit Margin
For every $100 in sales, HC Surgical Specialists Limited keeps $47.09 as profit after all expenses.
Operating Margin
Core operations generate 45.28 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $34.20 in profit for every $100 of shareholder equity.
ROA
HC Surgical Specialists Limited generates $24.75 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
HC Surgical Specialists Limited generates strong operating cash flow of $5.58M, reflecting robust business health.
Free Cash Flow
HC Surgical Specialists Limited generates strong free cash flow of $5.12M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.03 in free cash annually.
FCF Yield
1B1.SI converts 9.04% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
8.43
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.22
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.71
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.96
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.13
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.72
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.34
vs 25 benchmark
ROA
Return on assets percentage
0.25
vs 25 benchmark
ROCE
Return on capital employed
0.29
vs 25 benchmark
How 1B1.SI Stacks Against Its Sector Peers
| Metric | 1B1.SI Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 8.43 | 28.31 | Better (Cheaper) |
| ROE | 34.20% | 699.00% | Weak |
| Net Margin | 47.09% | -130884.00% (disorted) | Strong |
| Debt/Equity | 0.13 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 1.72 | 2775.16 | Neutral |
| ROA | 24.75% | -14469.00% (disorted) | Strong |
1B1.SI outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews HC Surgical Specialists Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation